Company intelligence / Profile preview
Damona Pharmaceuticals
Toronto, Ontario, Canadadamonapharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Preclinical data show that DPX‑101 reverses cognitive deficits induced by amyloid deposition in Alzheimer’s models and improves cognitive performance. The FDA has cleared an IND for Phase I trials to assess safety/tolerability. The company claims potential disease-modifying effects—restoring lost neuronal connections rather than just slowing decline.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- small molecules
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Centre for Addiction and Mental Health (CAMH) – scientific founding/collaboration/licensing partnerOntario Brain Institute – investor/supporterUWM Research Foundation Inc., University of Tours, University of Belgrade-Faculty of Pharmacy – licensors/academic partners for lead compound AC‑101/DPX‑101 development/licensing agreements.
Beyond the preview
Go deeper on Damona Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Damona Pharmaceuticals.